These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 27530860

  • 21. Contribution of the CmeABC efflux pump to macrolide and tetracycline resistance in Campylobacter jejuni.
    Gibreel A, Wetsch NM, Taylor DE.
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3212-6. PubMed ID: 17606685
    [Abstract] [Full Text] [Related]

  • 22. Heterogeneous macrolide resistance and gene conversion in the pneumococcus.
    Wolter N, Smith AM, Farrell DJ, Klugman KP.
    Antimicrob Agents Chemother; 2006 Jan; 50(1):359-61. PubMed ID: 16377711
    [Abstract] [Full Text] [Related]

  • 23. High-Level Macrolide-Resistant Moraxella catarrhalis and Development of an Allele-Specific PCR Assay for Detection of 23S rRNA Gene A2330T Mutation: A Three-Year Study at a Chinese Tertiary Hospital.
    Liu Y, Xu H, Xu Z, Kudinha T, Fan X, Xiao M, Kong F, Sun H, Xu Y.
    Microb Drug Resist; 2015 Oct; 21(5):507-11. PubMed ID: 25923017
    [Abstract] [Full Text] [Related]

  • 24. 23S rRNA mutation A2074C conferring high-level macrolide resistance and fitness cost in Campylobacter jejuni.
    Hao H, Dai M, Wang Y, Peng D, Liu Z, Yuan Z.
    Microb Drug Resist; 2009 Dec; 15(4):239-44. PubMed ID: 19857128
    [Abstract] [Full Text] [Related]

  • 25. Time-kill study of the activity of telithromycin against macrolide-resistant Streptococcus pneumoniae Isolates with 23S rRNA mutations and changes in ribosomal proteins L4 and L22.
    Reinert RR, Al-Lahham A.
    Antimicrob Agents Chemother; 2005 Jul; 49(7):3011-3. PubMed ID: 15980387
    [Abstract] [Full Text] [Related]

  • 26. Pneumococcal resistance to macrolides, lincosamides, ketolides, and streptogramin B agents: molecular mechanisms and resistance phenotypes.
    Edelstein PH.
    Clin Infect Dis; 2004 May 15; 38 Suppl 4():S322-7. PubMed ID: 15127365
    [Abstract] [Full Text] [Related]

  • 27. Two new point mutations at A2062 associated with resistance to 16-membered macrolide antibiotics in mutant strains of Mycoplasma hominis.
    Furneri PM, Rappazzo G, Musumarra MP, Di Pietro P, Catania LS, Roccasalva LS.
    Antimicrob Agents Chemother; 2001 Oct 15; 45(10):2958-60. PubMed ID: 11557502
    [Abstract] [Full Text] [Related]

  • 28. Activity of the novel macrolide BAL19403 against ribosomes from erythromycin-resistant Propionibacterium acnes.
    Dreier J, Amantea E, Kellenberger L, Page MG.
    Antimicrob Agents Chemother; 2007 Dec 15; 51(12):4361-5. PubMed ID: 17923495
    [Abstract] [Full Text] [Related]

  • 29. Mutations in a 23S rRNA gene of Chlamydia trachomatis associated with resistance to macrolides.
    Misyurina OY, Chipitsyna EV, Finashutina YP, Lazarev VN, Akopian TA, Savicheva AM, Govorun VM.
    Antimicrob Agents Chemother; 2004 Apr 15; 48(4):1347-9. PubMed ID: 15047540
    [Abstract] [Full Text] [Related]

  • 30. Emergence of fluoroquinolone-resistant Propionibacterium acnes caused by amino acid substitutions of DNA gyrase but not DNA topoisomerase IV.
    Nakase K, Sakuma Y, Nakaminami H, Noguchi N.
    Anaerobe; 2016 Dec 15; 42():166-171. PubMed ID: 27793740
    [Abstract] [Full Text] [Related]

  • 31. Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype.
    Gibreel A, Kos VN, Keelan M, Trieber CA, Levesque S, Michaud S, Taylor DE.
    Antimicrob Agents Chemother; 2005 Jul 15; 49(7):2753-9. PubMed ID: 15980346
    [Abstract] [Full Text] [Related]

  • 32. Lack of mutation in macrolide resistance genes in Chlamydia trachomatis clinical isolates with decreased susceptibility to azithromycin.
    Bhengraj AR, Srivastava P, Mittal A.
    Int J Antimicrob Agents; 2011 Aug 15; 38(2):178-9. PubMed ID: 21570258
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Propionibacterium acnes resistance: a worldwide problem.
    Eady EA, Gloor M, Leyden JJ.
    Dermatology; 2003 Aug 15; 206(1):54-6. PubMed ID: 12566805
    [Abstract] [Full Text] [Related]

  • 38. High prevalence of the A2058T macrolide resistance-associated mutation in Mycoplasma genitalium strains from the Netherlands.
    Braam JF, Slotboom B, Van Marm S, Severs TT, Van Maarseveen NM, Van Zwet T, Boel ECH, Berkhout H, Hagen F, Van De Bovenkamp JHB, Van Dommelen L, Kusters JG.
    J Antimicrob Chemother; 2017 May 01; 72(5):1529-1530. PubMed ID: 28158595
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.